Compagnie Lombard Odier S Cm A Obs Eva Sa Transaction History

Compagnie Lombard Odier S Cm A

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2019 Feb 13, 2020	BUY	$2.48 - $8.1 $3,968 - $12,960	1,600 Added 69.57%	3,900 $15,000
Q3 2018 Nov 13, 2018	BUY	$10.92 - $18.18 $25,116 - $41,814	2,300 New	2,300 $41,000

88K

Ticker OBSV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,499,200
Description
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometrio...

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.